Piramal Pharma announces $90m investment to expand US sites
Pharmaceutical Technology
JULY 1, 2025
The expansion will be concluded by late 2027, with production capacity increasing from 104 batches annually at peak utilisation to more than 240 batches. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address. Sign up for our daily news round-up!
Let's personalize your content